VIP analogues: a new neuroprotective approach to antiparkinsonian drug therapy Aug. 12, 1999 No Comments
Antiparkinsonian potential of 968, an active compound extracted from Chinese herbs Aug. 11, 1999 No Comments
Ropinirole is associated with a 15% lower risk of dyskinesia than L-dopa in early-stage PD patients Aug. 10, 1999 No Comments
Long-term effects of adenosine A2A receptor blockade with Sch-58261 in parkinsonian rats Aug. 10, 1999 No Comments
Levodopa prodrug TV-1203 is quickly and effectively hydrolyzed to active form following oral dosing Aug. 10, 1999 No Comments
L-Dopa-induced dyskinesia in primates is reduced significantly by coadministration of (-)-OSU-6162 Aug. 9, 1999 No Comments
Anecortave acetate: a novel angiostatic steroid for the treatment of ocular neovascular diseases Aug. 4, 1999 No Comments
RSS